nach oben

Cancer Causes & Control

Erschienen in:

11.12.2019 | Original Paper

Premenopausal gynecologic surgery and survival among black and white women with breast cancer

verfasst von: Mya L. Roberson, Hazel B. Nichols, Andrew F. Olshan, Melissa A. Troester, Whitney R. Robinson

Erschienen in: Cancer Causes & Control | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In the United States, hysterectomies and oophorectomies are frequently performed before menopause for benign conditions. The procedures are associated with reduced breast cancer-specific mortality among White women. The relationship between premenopausal gynecologic surgery and mortality in Black women with breast cancer is unknown.

Methods

This investigation used incident invasive cases of breast cancer from Phases 1 and 2 of the Carolina Breast Cancer Study a population-based study that recruited Black and White women in North Carolina between 1993 and 2001. Premenopausal gynecologic surgery was operationalized in three categories: no surgery; hysterectomy with bilateral oophorectomy; hysterectomy with conservation of ≥ 1 ovary. Mortality was ascertained using the National Death Index, last updated in 2016. Multivariable-adjusted Cox Proportional Hazard Models were used to estimate the effect of premenopausal surgery on breast cancer-specific and all-cause mortality

Results

Hysterectomy with bilateral oophorectomy was associated with reduced breast cancer-specific mortality (HR 0.68; 95% CI 0.49, 0.96). White and Black women had a similar reduction in breast cancer-specific mortality. (HR among white: 0.66; 95% CI 0.43, 1.02), (HR among Black: 0.67; 95% CI 0.37, 1.21).

Conclusions

There was a similar reduction in breast cancer-specific mortality following premenopausal, pre-diagnosis hysterectomy with bilateral oophorectomy across both Black and White women.

Howlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975–2014. (seer.cancer.gov/csr/1975_2014/), based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017.

DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017 racial disparity in mortality by state. CA Cancer J Clin. https://doi.org/10.3322/caac.21412 CrossRefPubMed

Daly B, Olopade OI (2015) A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin 65(3):221–238. https://doi.org/10.3322/caac.21271 CrossRefPubMed

Carey LA, Perou CM, Livasy CA et al (2006) Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502. https://doi.org/10.1001/jama.295.21.2492 CrossRefPubMed

DeSantis CE, Siegel L, Goding SA et al (2016) Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA Cancer J Clin 66(4):290–308. https://doi.org/10.3322/caac.21340 CrossRefPubMed

Reeder-Hayes KE, Anderson BO (2017) Breast cancer disparities at home and abroad: a review of the challenges and opportunities for system-level change. Clin Cancer Res 23(11):2655–2664. https://doi.org/10.1158/1078-0432.CCR-16-2630 CrossRefPubMedPubMedCentral

Toriola AT, Colditz GA (2013) Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat 138(3):665–673. https://doi.org/10.1007/s10549-013-2500-7 CrossRefPubMed

Hunt BR, Whitman S, Hurlbert MS (2014) Increasing Black: White disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 38(2):118–123. https://doi.org/10.1016/j.canep.2013.09.009 CrossRefPubMed

Silber JH, Rosenbaum PR, Clark AS et al (2013) Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310(4):389–397. https://doi.org/10.1001/jama.2013.8272 CrossRefPubMed

10.

Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66(1):7–30. https://doi.org/10.3322/caac.21332 CrossRefPubMed

11.

Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE (2010) Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol 202(6):514–521. https://doi.org/10.1016/j.ajog.2010.02.039 CrossRefPubMedPubMedCentral

12.

Hartmann LC, Lindor NM (2016) The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374(5):454–468. https://doi.org/10.1056/NEJMra1503523 CrossRefPubMed

13.

Centers for Disease Control and Prevention (CDC) (2012) Behavioral risk factors surveillance system survey data. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta

14.

Jacoby VL, Vittinghoff E, Nakagawa S et al (2009) Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol 113(6):1,259–1,267. https://doi.org/10.1097/AOG.0b013e3181a66c42 CrossRef

15.

Powell LH, Meyer P, Weiss G et al (2005) Ethnic differences in past hysterectomy for benign conditions. Women’s Heal Issues 15(4):179–186. https://doi.org/10.1016/j.whi.2005.05.002 CrossRef

16.

Bower JK, Schreiner PJ, Sternfeld B, Lewis CE (2009) Black-white differences in hysterectomy prevalence: the CARDIA study. Am J Public Health 99(2):300–307. https://doi.org/10.2105/AJPH.2008.133702 CrossRefPubMedPubMedCentral

17.

Robinson WR, Nichols HB, Tse CK, Olshan AF, Troester MA (2016) Associations of premenopausal hysterectomy and oophorectomy With breast cancer among black and white women: the carolina breast cancer study, 1993–2001. Am J Epidemiol 184(5):388–399. https://doi.org/10.1093/aje/kwv448 CrossRefPubMedPubMedCentral

18.

Boggs DA, Palmer JR, Rosenberg L (2014) Bilateral oophorectomy and risk of cancer in African American women. Cancer Causes Control 25(4):507–513. https://doi.org/10.1007/s10552-014-0353-y CrossRefPubMedPubMedCentral

19.

Parker WH, Broder MS, Chang E et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113(5):1,027–1,037. https://doi.org/10.1097/AOG.0b013e3181a11c64 CrossRefPubMedPubMedCentral

20.

Nichols HB, Trentham-Dietz A, Newcomb PA et al (2013) Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer. Breast Cancer Res 15(5):R99. https://doi.org/10.1186/bcr3560 CrossRefPubMedPubMedCentral

21.

Newman B, Moorman PG, Millikan R et al (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35(1):51–60. https://doi.org/10.1007/BF00694745 CrossRefPubMed

22.

Weinberg CR, Wacholder S (1990) The design and analysis of case-control studies with biased sampling. Biometrics 46(4):963–975. https://doi.org/10.2307/2532441 CrossRefPubMed

23.

DeBono NL, Robinson WR, Lund JL et al (2018) Race, menopausal hormone therapy, and invasive breast cancer in the carolina breast cancer study. J Women’s Heal 27(3):377–386. https://doi.org/10.1089/jwh.2016.6063 CrossRef

24.

Moorman P, Newman B, Millikan R, Tse C-K, Sandler D (1999) Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 9(3):188–195. https://doi.org/10.1016/S1047-2797(98)00057-X CrossRefPubMed

25.

Lin DY, Wei LJ (1989) The robust inference for the cox proportional hazards model. J Am Stat Assoc 84(408):1074–1078. https://doi.org/10.1080/01621459.1989.10478874 CrossRef

26.

Leon AC, Heo M (2009) Sample sizes required to detect interactions between two binary fixed-effects in a mixed-effects linear regression model. Comput Stat Data Anal 53(3):603–608. https://doi.org/10.1016/j.csda.2008.06.010 CrossRefPubMedPubMedCentral

27.

Greenland S (1983) Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med 2(2):243–251. https://doi.org/10.1002/sim.4780020219 CrossRefPubMed

28.

Welsh ML, Buist DSM, Aiello Bowles EJ, Anderson ML, Elmore JG, Li CI (2009) Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history. Breast Cancer Res Treat 114(3):549–558. https://doi.org/10.1007/s10549-008-0026-1 CrossRefPubMed

29.

Barnard ME, Boeke CE, Tamimi RM (2015) Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta 1856(1):73–85. https://doi.org/10.1016/J.BBCAN.2015.06.002 CrossRefPubMed

30.

Doll KM, Dusetzina SB, Robinson W (2016) Trends in inpatient and outpatient hysterectomy and oophorectomy rates among commercially insured women in the United States, 2000–2014. JAMA Surg 151(9):876. https://doi.org/10.1001/jamasurg.2016.0804 CrossRefPubMedPubMedCentral

31.

Obermair A, Youlden DR, Baade PD, Janda M (2014) The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer—a population-based data linkage study. Int J Cancer 134(9):2211–2222. https://doi.org/10.1002/ijc.28537 CrossRefPubMed

32.

Obermair A, Youlden D, Baade P, Janda M (2017) Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study. Asia Pac J Clin Oncol 13(1):68–78. https://doi.org/10.1111/ajco.12508 CrossRefPubMed

33.

Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in brca1 or brca2 mutation carriers with cancer risk and mortality. JAMA 304(9):967. https://doi.org/10.1001/jama.2010.1237 CrossRefPubMedPubMedCentral

34.

Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL (2016) Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg 212(4):660–669. https://doi.org/10.1016/j.amjsurg.2016.06.010 CrossRefPubMed

35.

McCarthy AM, Menke A, Ouyang P, Visvanathan K (2012) Bilateral Oophorectomy, Body mass index, and mortality in US women aged 40 years and older. Cancer Prev Res 5(6):847–854. https://doi.org/10.1158/1940-6207.CAPR-11-0430 CrossRef

36.

Phipps AI, Buist DSM (2009) Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause 16(3):576–581. https://doi.org/10.1097/gme.0b013e31818ffe28 CrossRefPubMedPubMedCentral

Titel: Premenopausal gynecologic surgery and survival among black and white women with breast cancer
verfasst von: Mya L. Roberson
Hazel B. Nichols
Andrew F. Olshan
Melissa A. Troester
Whitney R. Robinson
Publikationsdatum: 11.12.2019
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 2/2020
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-019-01255-2

Springer Medizin

Premenopausal gynecologic surgery and survival among black and white women with breast cancer

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

The association between diet quality and cancer incidence of the head and neck

Immigration history, lifestyle characteristics, and breast density in the Vietnamese American Women’s Health Study: a cross-sectional analysis

Sexual orientation and benign breast disease in a cohort of U.S. women

Case–control study of endogenous sex steroid hormones and risk of endometrial cancer

Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study

Alcohol consumption and serum metabolite concentrations in young women

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie